News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sanofi (France) (SAN.PA) Signs MOU for Rare Disease Collaboration With Sinopharm Group


10/1/2012 1:08:08 PM

by Richard Daverman, PhD

October 1, 2012 -- Sanofi and Sinopharm (China State Institute of Pharmaceutical Industry) signed a MOU in Shanghai to conduct joint research into rare diseases. Although details haven’t been released, the collaboration will apparently survey the incidence of rare diseases in China, then seek to understand causes and find treatments. In 2011, Sanofi paid $20 billion to acquire US-based Genzyme, a specialist in rare diseases. More details....

Stock Symbol: (NYSE: SNY)


Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES